[1] Sasaki H, Kohsaka H. Current diagnosis and treatment of polymyositis and dermatomyositis [J]. Mod Rheumatol, 2018, 28(6): 913-921.
[2] Yan W, Chen C, Chen H. Estrogen downregulates miR-21 expression and induces inflammatory infiltration of macrophages in polymyositis: role of CXCL10 [J]. Mol Neurobiol, 2017, 54(3): 1631-1641.
[3] Yu L, Yu L, Pham Q, et al. Transcriptional and translational-uncoupling in regulation of the CXCL12 and its receptors CXCR4, 7 in THP-1 monocytes and macrophages[J]. Immun Inflamm Dis,2018,6(1):106-116.
[4] Kuang L, Wu J, Su N, et al. FGFR3 deficiency enhances CXCL12-dependent chemotaxis of macrophages via upregulating CXCR7 and aggravates joint destruction in mice[J]. Ann Rheum Dis, 2020, 79(1): 112-122.
[5] Zhu J, Liu B, Wang Z, et al. Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p/PTEN-mediated VSMC migration and proliferation [J]. Theranostics,2019, 9(23): 6901-6919.
[6] Liu WH, Yu X, Ren Y, et al. MicroRNA-140-5p promotes the proliferation of renal cancer cells through protein kinase C subtype ε [J]. Acta Anatomy Sinica, 2019, 50(2):185-191. (in Chinese)
刘伟红, 余肖, 任雨, 等. MicroRNA-140-5p通过蛋白激酶C亚型ε促进肾癌细胞增殖[J]. 解剖学报, 2019, 50(2):185-191.
[7] Song K, Li L, Sun G, et al. MicroRNA-381 regulates the occurrence and immune responses of coronary atherosclerosis via cyclooxygenase-2[J]. Exp Ther Med, 2018, 15(5): 4557-4563.
[8] Lim HX, Jung HJ, Lee A, et al. Lysyl-transfer RNA synthetase induces the maturation of dendritic cells through MAPK and NF-κB pathways, strongly contributing to enhanced Th1 cell responses[J]. J Immunol, 2018, 201(9): 2832-2841.
[9] Lee JS, Kwak G, Kim HJ, et al. miR-381 attenuates peripheral neuropathic phenotype caused by overexpression of PMP22 [J]. Exp Neurobiol, 2019, 28(2): 279-288.
[10] Motomura K, Yamashita H, Yamada S, et al. Clinical characteristics and prognosis of polymyositis and dermatomyositis associated with malignancy: a 25-year retrospective study [J]. Rheumatol Int, 2019, 39(10): 1733-1739.
[11] Sugiyama Y, Yoshimi R, Takeno M, et al. miR-1 is a novel biomarker for polymyositis/dermatomyositis-associated interstitial lung disease [J]. Mod Rheumatol, 2020, 30(5): 878-883.
[12] Jiang T, Huang Y, Liu H, et al. Reduced miR-146a promotes REG3A expression and macrophage migration in polymyositis and dermatomyositis [J]. Front Immunol, 2020, 11(1): 37-41.
[13] Lin CC, Law BF, Hettick JM. Acute 4, 4’-methylene diphenyl diisocyanate exposure-mediated downregulation of miR-206-3p and miR-381-3p activates inducible nitric oxide synthase transcription by targeting calcineurin/NFAT signaling in macrophages[J]. Toxicol Sci, 2020, 173(1): 100-113.
[14] Liu Y, Gao Y, Yang J, et al. MicroRNA-381 reduces inflammation and infiltration of macrophages in polymyositis via downregulating HMGB1 [J]. Int J Oncol, 2018, 53(3):1332-1342.
[15] Citro A, Pellegrini S, Dugnani E, et al. CCL2/MCP-1 and CXCL12/SDF-1 blockade by L-aptamers improve pancreatic islet engraftment and survival in mouse [J]. Am J Transplant, 2019, 19(11): 3131-3138.
[16] Zeng Y, Li B, Liang Y, et al. Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment [J]. FASEB J, 2019, 33(5): 6596-6608.
[17] Tian Y, Matsui S, Touma M, et al. MicroRNA-342 inhibits tumor growth via targeting chemokine CXCL12 involved in macrophages recruitment/activation[J]. Genes Cells, 2018, 23(12): 1009-1022.
[18] Piao JM, Wu W, Yang ZX, et al. MicroRNA-381 favors repair of nerve injury through regulation of the SDF-1/CXCR4 signaling pathway via LRRC4 in acute cerebral ischemia after cerebral lymphatic blockage[J]. Cell Physiol Biochem, 2018, 46(3): 890-906.
[19] Zheng GH, Wen X, Wang YJ, et al. MicroRNA-381-induced down-regulation of CXCR4 promotes the proliferation of renal tubular epithelial cells in rat models of renal ischemia reperfusion injury [J]. J Cell Biochem, 2018, 119(4): 3149-3161.
[20] Fang Z, Zhong M, Wang Y, et al. miR-381 and miR-489 suppress cell proliferation and invasion by targeting CUL4B via the Wnt/β-catenin pathway in gastric cancer [J]. Int J Oncol, 2019, 54(2): 733-743.
[21] Zhu XS, Zhou HY, Yang F, et al. miR-381-3p inhibits high glucose-induced vascular smooth muscle cell proliferation and migration by targeting HMGB1 [J]. J Gene Med, 2020, 9(9): e3274-e-3278.
|